Brooks Laboratories Ltd vs Kerala Ayurveda Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Brooks Laboratories Ltd is ₹ 66.39 as of 12 Jun 15:30 . The P/E Ratio of Brooks Laboratories Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Kerala Ayurveda Ltd changed from 34.9 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of Brooks Laboratories Ltd changed from ₹ 153.53 crore on March 2021 to ₹ 317.37 crore on March 2025 . This represents a CAGR of 15.63% over 5 yearsThe Market Cap of Kerala Ayurveda Ltd changed from ₹ 54.23 crore on March 2021 to ₹ 422.58 crore on March 2025 . This represents a CAGR of 50.78% over 5 years The revenue of Brooks Laboratories Ltd for the Mar '26 is ₹ 21.56 crore as compare to the Dec '25 revenue of ₹ 21.89 crore. This represent the decline of -1.51% The revenue of Kerala Ayurveda Ltd for the Mar '26 is ₹ 36.64 crore as compare to the Dec '25 revenue of ₹ 34.09 crore. This represent the growth of 7.48% The ebitda of Brooks Laboratories Ltd for the Mar '26 is ₹ 2.02 crore as compare to the Dec '25 ebitda of ₹ 6.05 crore. This represent the decline of -66.61% The ebitda of Kerala Ayurveda Ltd for the Mar '26 is ₹ -5.19 crore as compare to the Dec '25 ebitda of ₹ -0.38 crore. This represent the growth of 1265% The net profit of Brooks Laboratories Ltd changed from ₹ -2.41 crore to ₹ 1.52 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Kerala Ayurveda Ltd changed from ₹ 0.46 crore to ₹ -7.4 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Brooks Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kerala Ayurveda Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Brooks Laboratories Ltd

Brooks Laboratories Limited was incorporated on January 23, 2002.
The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers.
The Company is a pharmaceutical manufacturing company working on contract basis and have its own marketing team to cater the critical care segment.
It offer a variety of dosage from Beta lactam Tablets, Beta lactam Dry Syrup, General Injections, Liquid Injections, Dry Powder Injections, and Eye/Ear Drops, Oncology Products, Hormonal Injections etc. The company's manufacturing facilities are designed to manufacture a variety of products in the formulation segment using a combination of processes.
At Baddi, they manufacture wide range of products under the formulation segment for various top notch companies of India.

About Kerala Ayurveda Ltd

Kerala Ayurveda Limited was established on 6th July 1992.
The Company is engaged in manufacture of Ayurveda products, Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services , cultivation of herbs and maintaining herbarium of medicinal plants.
The Company emerged as a frontline manufacturer of speciality patent ayurvedic medicines - tussnil, liposem and mathrukalpam. The company came out with a public issue in Feb.'95 to part-finance its 7-cr expansion-cum-diversification programme which involve, expansion of its existing facilities; to develop a fully integrated health care system, cultivate medicinal plants and market ayurvedic medicines.
It also envisions setting up a hospital. A modern facility to manufacture patent medicines, tablets, capsules and syrups, is to be set up at Athani, near Alwaye.

FAQs for the comparison of Brooks Laboratories Ltd and Kerala Ayurveda Ltd

Which company has a larger market capitalization, Brooks Laboratories Ltd or Kerala Ayurveda Ltd?

Market cap of Brooks Laboratories Ltd is 195 Cr while Market cap of Kerala Ayurveda Ltd is 225 Cr

What are the key factors driving the stock performance of Brooks Laboratories Ltd and Kerala Ayurveda Ltd?

The stock performance of Brooks Laboratories Ltd and Kerala Ayurveda Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Brooks Laboratories Ltd and Kerala Ayurveda Ltd?

As of June 14, 2026, the Brooks Laboratories Ltd stock price is INR ₹66.39. On the other hand, Kerala Ayurveda Ltd stock price is INR ₹173.75.

How do dividend payouts of Brooks Laboratories Ltd and Kerala Ayurveda Ltd compare?

To compare the dividend payouts of Brooks Laboratories Ltd and Kerala Ayurveda Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.